Endocrine Technology Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • (Cancelled)
  • Latest Deal Amount
  • $20M
Latest Deal Amount

Endocrine Technology General Information

Description

Owner and operator of a biotechnology company. The company focuses on filing New patent applications for the therapy of diabetes and its complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 326 Livingston Street
  • New York, NY 11217
  • United States
+1 (718) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocrine Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC $20M Cancelled Startup
2. Grant 00.00 00.00 Completed Startup
1. Angel (individual) $2.2M $2.2M Completed Startup
To view Endocrine Technology’s complete valuation and funding history, request access »

Endocrine Technology Executive Team (1)

Name Title Board Seat Contact Info
Kumarpal Shah MD Founder, Owner & President, Business Development
To view Endocrine Technology’s complete executive team members history, request access »